Submitted by David Rhee
It is my distinct pleasure to announce the winner of the 2019 American Chemical Society, St. Louis Section, Chemical Science and Technology Award; Sally W. Schwarz, R. Ph., M.S., B.C.N.P. Currently a Professor of Radiology and co-director of Cyclotron Facility at Washington University in St. Louis, she has made outstanding contributions to radiopharmaceutical sciences over three decades. She has worked both in clinical nuclear medicine and in radiochemistry research in development of new radiopharmaceuticals and in translation of those radiopharmaceuticals to humans for diagnostic use.
Professor Schwarz is one of the most recognized radiopharmacist, both nationally and internationally where she made contributions in the scientific, educational, regulatory domains over decades. She served on the United States Pharmacopeia (USP) Expert Committee for 10 years, involved in revising definition of the production and quality control requirements of PET radiopharmaceuticals for research use. She is a member of the American Pharmacists Association (APhA) and the Nuclear Pharmacy Special Interest Group and became an APhA fellow in 2009. She also served as the Nuclear Pharmacy advocate on the Nuclear Regulatory Commission (NRC) Advisory Committee for the Medical Use of Isotopes (ACMUI) for 6 years. She was a past President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). She has been involved in training pharmacy students as part of the PharmD program at St. Louis College of Pharmacy and the University of New Mexico.
She believes in the science of Nuclear Medicine and that it brings tremendous benefit to the patients. During her career, she had one major goal, to provide high quality clinical and clinical research radiopharmaceuticals for the patients. She believes she has achieved this goal, though she will always continue to pursue it.